Pharmaceuticals in Taiwan


November 21, 2012
36 Pages - SKU: MTLN4921410
License type:
Countries covered: Taiwan

Introduction

Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Taiwan pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Taiwanese pharmaceuticals market had total revenues of $4.8 billion in 2011, representing a compound annual growth rate (CAGR) of 6.3% between 2007 and 2011.
  • The performance of the market is forecast to accelerate, with an anticipated CAGR of 7.3% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $6.8 billion by the end of 2016.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Taiwan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Taiwan

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Taiwan pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Taiwan economy

Key Questions Answered

What was the size of the Taiwan pharmaceuticals market by value in 2011?

What will be the size of the Taiwan pharmaceuticals market in 2016?

What factors are affecting the strength of competition in the Taiwan pharmaceuticals market?

How has the market performed over the last five years?



More Country Overviews reports by MarketLine

Pharmaceuticals: Global Industry Guide by MarketLine
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on ...
Pharmaceuticals: Global Industry Almanac by MarketLine
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and ...
Pharmaceuticals - North America (NAFTA) Industry Guide by MarketLine
Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North ...
Pharmaceuticals - Global Group of Eight (G8) Industry Guide by MarketLine
Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of ...
See all reports like this >>

More Taiwan Country Overviews reports

Taiwan Pharmaceutical Market Outlook 2013 by GBI Research
Taiwan Pharmaceutical Market Outlook 2013SummaryGBI Research, the leading business intelligence provider, has released its latest research Taiwan Pharmaceutical Market Outlook 2013. The report focuses on ...
Taiwan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Taiwan will continue to represent a modestly attractive proposition for drug manufactures. Ourview is based on factors such as the maturity of its ...
Taiwan Pharmaceuticals and Healthcare Report Q1 2013 by Business Monitor International
BMI View: We continue to view Taiwan as a challenging market for multinationals, mostly on account ofthe difficult pricing and reimbursement environment, which is due ...
Taiwan Pharmaceuticals and Healthcare Report Q3 2012 by Business Monitor International
BMI View: We do not expect Taiwan's healthcare expenditure to reach the government's target of 7.5% of GDP in the short to medium term – ...
See all reports like this >>

More Taiwan reports

D&B Country RiskLine Report: Taiwan by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Datamonitor's Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!